These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34330191)

  • 1. Evaluation of species differences in the metabolism of the selective Na
    Asano D; Shibayama T; Shiozawa H; Inoue SI; Shinozuka T; Murata S; Watanabe N; Yoshinari K
    Xenobiotica; 2021 Sep; 51(9):1060-1070. PubMed ID: 34330191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2C8-Mediated Formation of a Human Disproportionate Metabolite of the Selective Na
    Asano D; Hamaue S; Zahir H; Shiozawa H; Nishiya Y; Kimura T; Kazui M; Yamamura N; Ikeguchi M; Shibayama T; Inoue SI; Shinozuka T; Watanabe T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2022 Mar; 50(3):235-242. PubMed ID: 34930785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective Na
    Asano D; Nakamura K; Nishiya Y; Shiozawa H; Takakusa H; Shibayama T; Inoue SI; Shinozuka T; Hamada T; Yahara C; Watanabe N; Yoshinari K
    Drug Metab Dispos; 2023 Jan; 51(1):67-80. PubMed ID: 36273823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.
    Crouch RD; Morrison RD; Byers FW; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2016 Aug; 44(8):1296-303. PubMed ID: 26936972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401.
    Zhang JW; Deng HB; Zhang CY; Dai JQ; Li Q; Zheng QG; Wan HX; Yu HP; He F; Xu YC; Zhao S; Zhang JYJ
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):669-680. PubMed ID: 31030415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu
    Crouch RD; Blobaum AL; Felts AS; Conn PJ; Lindsley CW
    Drug Metab Dispos; 2017 Dec; 45(12):1245-1259. PubMed ID: 28939686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Carbazeran 4-Oxidation and
    Xie J; Saburulla NF; Chen S; Wong SY; Yap ZP; Zhang LH; Lau AJ
    Drug Metab Dispos; 2019 Jan; 47(1):26-37. PubMed ID: 30337443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Aldehyde Oxidase in the Metabolic Clearance of Substituted Benzothiazoles.
    Teffera Y; Liu J; Krolikowski P; Zhao Z
    Drug Metab Lett; 2021; 14(2):126-136. PubMed ID: 34818997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
    Nishimuta H; Watanabe T; Bando K
    AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications.
    Diamond S; Boer J; Maduskuie TP; Falahatpisheh N; Li Y; Yeleswaram S
    Drug Metab Dispos; 2010 Aug; 38(8):1277-85. PubMed ID: 20421447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5.
    Morrison RD; Blobaum AL; Byers FW; Santomango TS; Bridges TM; Stec D; Brewer KA; Sanchez-Ponce R; Corlew MM; Rush R; Felts AS; Manka J; Bates BS; Venable DF; Rodriguez AL; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2012 Sep; 40(9):1834-45. PubMed ID: 22711749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase.
    Isobe T; Ohta M; Kaneko Y; Kawai H
    Xenobiotica; 2016 Jul; 46(7):579-590. PubMed ID: 26678038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative metabolic pathway of lenvatinib mediated by aldehyde oxidase.
    Inoue K; Mizuo H; Kawaguchi S; Fukuda K; Kusano K; Yoshimura T
    Drug Metab Dispos; 2014 Aug; 42(8):1326-33. PubMed ID: 24914245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism of simazine, atrazine and propazine by hepatic cytochrome P450 enzymes of rat, mouse and guinea pig, and oestrogenic activity of chlorotriazines and their main metabolites.
    Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
    Xenobiotica; 1999 Dec; 29(12):1213-26. PubMed ID: 10647908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes.
    Yamazaki H; Shimada T
    Xenobiotica; 1998 Oct; 28(10):995-1004. PubMed ID: 9849646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.
    Akabane T; Tanaka K; Irie M; Terashita S; Teramura T
    Xenobiotica; 2011 May; 41(5):372-84. PubMed ID: 21385103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
    Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
    Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.